Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...

Each year, The Michael J. Fox Foundation (MJFF) hosts the Parkinson’s Disease Therapeutics Conference (PDTC), the world’s only scientific meeting devoted exclusively to Parkinson’s drug development.

Today, a Parkinson's diagnosis is made based on a person's symptoms and medical history. Scientists are working to develop tools and biomarkers that could help identify Parkinson's earlier and give ...

Neurology residents explore Parkinson's care, research advances and career opportunities at the 2026 MDS-PAS Movement Disorders School.

This election season, California voters are considering Proposition 38, a ballot measure that would authorize $8.4 billion in state bonds for immunology and immunotherapy research at California ...